FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387063004: Oxybuprocaine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1481177015 Benoxinate hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2693749019 Oxybuprocaine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3695732010 Oxybuprocaine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
44251000188118 oxybuprocaÏne chlorhydrate fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybuprocaine hydrochloride Is a Oxybuprocaine false Inferred relationship Some
Oxybuprocaine hydrochloride Is a allergène médicamenteux false Inferred relationship Some
Oxybuprocaine hydrochloride Is a Topical anesthetic false Inferred relationship Some
Oxybuprocaine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Oxybuprocaine true Inferred relationship Some
Oxybuprocaine hydrochloride Is a Anesthetic (substance) false Inferred relationship Some
Oxybuprocaine hydrochloride Is a Benzoic acid ester and/or benzoic acid ester derivative (substance) false Inferred relationship Some
Oxybuprocaine hydrochloride Is a Benzoic acid ester local anesthetic true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Benoxinate hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Oxybuprocaine poisoning Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Accidental oxybuprocaine poisoning Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Intentional oxybuprocaine poisoning Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Oxybuprocaine poisoning of undetermined intent Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Oxybuprocaine adverse reaction Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some 1
Allergy to oxybuprocaine Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Oxybuprocaine overdose Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some 1
Accidental oxybuprocaine overdose (disorder) Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some 1
Intentional oxybuprocaine overdose Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some 1
Oxybuprocaine overdose of undetermined intent Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some 1
Oxybuprocaine hydrochloride 0.4% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Fluorescein sodium and oxybuprocaine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Benoxinate hydrochloride 0.2% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Benoxinate hydrochloride 0.4% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Accidental oxybuprocaine poisoning Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Intentional oxybuprocaine poisoning Causative agent (attribute) False Oxybuprocaine hydrochloride Inferred relationship Some
Oxybuprocaine hydrochloride 0.4% conventional release eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxybuprocaine hydrochloride Inferred relationship Some
Product containing precisely oxybuprocaine hydrochloride 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Oxybuprocaine hydrochloride Inferred relationship Some 1
Product containing precisely oxybuprocaine hydrochloride 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Oxybuprocaine hydrochloride Inferred relationship Some 1
Oxybuprocaine hydrochloride 4 mg/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxybuprocaine hydrochloride Inferred relationship Some 1
Oxybuprocaine hydrochloride 4 mg/mL eye drops This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxybuprocaine hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start